◆英語タイトル:Tecan Group Ltd (TECN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011955
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月14日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation suppliers. Its product portfolio encompasses liquid handling and robotics, reader and washer, microarray products, components, software, and consumables. Tecan’s products find applications in agriculture, forensic solutions, analytical chemistry, cell biology, drug discovery, genomic solutions, protein science solutions, ELISA solutions and synthetic biology. The company has manufacturing facilities, and research and development facilities in Europe and North America. Tecan is headquartered in Mannedorf, Zurich, Switzerland.
Tecan Group Ltd (TECN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tecan Group Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Tecan Group Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Tecan Group Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Tecan Group Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Tecan Group Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Tecan Group Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 10
IBL International And Leiden University Medical Centre Enter Into Licensing Agreement For Myasthenia Gravis Diagnostics 11
Radisens Enters Into Licensing Agreement With Tecan 12
Tecan Signs Licensing And Collaboration Agreement With Enigma Diagnostics 13
DiaSorin Enters into Agreement with Tecan 14
Singulex Enters Into Co-Development Agreement With Tecan 15
ViroGates Enters Into Distribution Agreement With IBL International 16
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 17
IBL International Enters Into Distribution Agreement With Sanquin Blood Supply Foundation 18
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 19
Reinnervate Enters Into Co-Development Agreement With Tecan Group 20
University of Duisburg-Essen Enters Into Licensing Agreement With IBL International 21
Acquisition 22
Tecan Acquires SPEware 22
Tecan Completes Acquisition of IBL International for USD39 Million 23
Tecan Group Ltd – Key Competitors 24
Tecan Group Ltd – Key Employees 25
Tecan Group Ltd – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Financial Announcements 28
Aug 16, 2017: H1 2017: Tecan with significant increase in order entry and strong sales growth in the Life Sciences Business 28
Mar 15, 2017: Full year 2016: Another year of double-digit sales growth for Tecan 31
Corporate Communications 34
Oct 06, 2017: Tecan initiates succession process for the Board of Directors 34
Jun 02, 2017: Tecan appoints Erik Norstrom Head of Corporate Development 35
Jun 02, 2017: Tecan appoints Erik Norstrom Head of Corporate Development 36
Jan 10, 2017: Tecan appoints Klaus Lun Head of the Life Sciences Business division 37
Dec 14, 2016: Tecan announces change in Management Board 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
Tecan Group Ltd, Medical Equipment, Key Facts, 2016 2
Tecan Group Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Tecan Group Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Tecan Group Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Tecan Group Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Tecan Group Ltd, Deals By Market, 2011 to YTD 2017 8
Tecan Group Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 10
IBL International And Leiden University Medical Centre Enter Into Licensing Agreement For Myasthenia Gravis Diagnostics 11
Radisens Enters Into Licensing Agreement With Tecan 12
Tecan Signs Licensing And Collaboration Agreement With Enigma Diagnostics 13
DiaSorin Enters into Agreement with Tecan 14
Singulex Enters Into Co-Development Agreement With Tecan 15
ViroGates Enters Into Distribution Agreement With IBL International 16
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 17
IBL International Enters Into Distribution Agreement With Sanquin Blood Supply Foundation 18
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 19
Reinnervate Enters Into Co-Development Agreement With Tecan Group 20
University of Duisburg-Essen Enters Into Licensing Agreement With IBL International 21
Tecan Acquires SPEware 22
Tecan Completes Acquisition of IBL International for USD39 Million 23
Tecan Group Ltd, Key Competitors 24
Tecan Group Ltd, Key Employees 25
Tecan Group Ltd, Subsidiaries 26